Skip to content

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

BioHarvest Sciences (CSE:BHSC) CEO, Ilan Sobel, discusses US partnership and Growth Strategy

← Previous Media Video

Next Media Video →

Search

Recent Posts

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
BIOHARVEST SCIENCES ANNOUNCES CLOSING OF $19.9 MILLION UPSIZED PUBLIC OFFERING OF COMMON STOCK AND EXERCISE OF UNDERWRITER’S OPTION TO PURCHASE ADDITIONAL SHARES
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Recent Comments

No comments to show.

Archives

Categories

2020
2021
2022
2023
2024
2025
Uncategorized

Join Our Newsletter

Be the first to receive our news alerts, event notifications, and product releases.

Revolution

Facebook X-twitter Linkedin Youtube

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors